Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport

Abstract

The human multidrug transporter MDR1 P-glycoprotein and the multidrug resistance proteins MRP1 and MRP2 transport a range of cytotoxic drugs, resulting in multidrug resistance in tumour cells. To overcome this form of drug resistance in patients, several inhibitors (reversal agents) of these transporters have been isolated. Using polarized cell lines stably expressing human MDR1, MRP1 or MRP2cDNA, and 2008 ovarian carcinoma cells stably expressing MRP1 cDNA, we have investigated in this study the specificity of the reversal agents V-104 (a pipecolinate derivative), GF120918 (an acridone carboxamide derivative also known as GG918), and Pluronic L61 (a (poly)oxypropethylene and (poly)oxypropylene block copolymer). Transport experiments with cytotoxic drugs with polarized cell lines indicate that all three compounds efficiently inhibit MDR1 Pgp. Furthermore, V-104 partially inhibits daunorubicin transport by MRP1 but not vinblastine transport by MRP2. V-104 reverses etoposide resistance of 2008/MRP1 cells, whereas GF120918 does not reverse resistance due to MRP1. V-104 partially inhibits the export of the organic anion dinitrophenyl S-glutathione by MDCKII-MRP1 but not by MDCKII-MRP2 cells. Unexpectedly, export of the organic anion calcein by MDCKII-MRP1 and MDCKII-MRP2 cells is stimulated by Pluronic L61, probably because it relieves the block on entry of calcein AM into the cell by endogenous MDR1 Pgp.

References 47

1. 1.

   Bakos E., Evers R., Szakács G., Tusnády G. E., Welker E., Szabó K., de Haas M., van Deemter L., Borst P., Váradi A. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem. 1998;273(48):32167-32175.

   Not in our library10.1074/jbc.273.48.32167

2. 2.
   Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity · 1996

   No notice
3. 3.

   Batrakova E. V., Han H. Y., Miller D. W., Kabanov A. V. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res. 1998;15(10):1525-1532.

   Not in our library10.1023/a:1011942814300

4. 4.

   Böhme M., Büchler M., Müller M., Keppler D. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett. 1993;333(1-2):193-196.

   Not in our library10.1016/0014-5793(93)80403-h

5. 5.

   Chen Z. S., Kawabe T., Ono M., Aoki S., Sumizawa T., Furukawa T., Uchiumi T., Wada M., Kuwano M., Akiyama S. I. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol. 1999;56(6):1219-1228.

   Not in our library10.1124/mol.56.6.1219

6. 6.

   Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M., Deeley R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258(5088):1650-1654.

   Not in our library10.1126/science.1360704

7. 7.

   Cole S. P., Deeley R. G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays. 1998;20(11):931-940.

   Not in our library10.1002/(sici)1521-1878(199811)20:11<931::aid-bies8>3.0.co;2-j

8. 8.

   Cui Y., König J., Buchholz J. K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol. 1999;55(5):929-937.

   Not in our library

9. 9.

   Evers R., Cnubben N. H., Wijnholds J., van Deemter L., van Bladeren P. J., Borst P. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett. 1997;419(1):112-116.

   Not in our library10.1016/s0014-5793(97)01442-7

10. 10.

    Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L. C., Paulusma C. C., Oude Elferink R. P., Baas F., Schinkel A. H. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest. 1998;101(7):1310-1319.

    Not in our library10.1172/jci119886

11. 11.

    Evers R., Zaman G. J., van Deemter L., Jansen H., Calafat J., Oomen L. C., Oude Elferink R. P., Borst P., Schinkel A. H. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest. 1996;97(5):1211-1218.

    Not in our library10.1172/jci118535

12. 12.
    Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export · 2000

    No notice
13. 13.

    Feller N., Broxterman H. J., Währer D. C., Pinedo H. M. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett. 1995;368(2):385-388.

    Not in our library10.1016/0014-5793(95)00677-2

14. 14.

    Fisher G. A., Sikic B. I. Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am. 1995;9(2):363-382.

    Not in our library

15. 15.

    Germann U. A., Ford P. J., Shlyakhter D., Mason V. S., Harding M. W. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anticancer Drugs. 1997;8(2):141-155.

    Not in our library10.1097/00001813-199702000-00005

16. 16.

    Germann U. A., Shlyakhter D., Mason V. S., Zelle R. E., Duffy J. P., Galullo V., Armistead D. M., Saunders J. O., Boger J., Harding M. W. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro. Anticancer Drugs. 1997;8(2):125-140.

    Not in our library10.1097/00001813-199702000-00004

17. 17.

    Gottesman M. M., Hrycyna C. A., Schoenlein P. V., Germann U. A., Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet. 1995;29:607-649.

    Not in our library10.1146/annurev.ge.29.120195.003135

18. 18.

    Hirohashi T., Suzuki H., Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem. 1999;274(21):15181-15185.

    Not in our library10.1074/jbc.274.21.15181

19. 19.

    Holló Z., Homolya L., Hegedüs T., Sarkadi B. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett. 1996;383(1-2):99-104.

    Not in our library10.1016/0014-5793(96)00237-2

20. 20.

    Homolya L., Holló M., Müller M., Mechetner E. B., Sarkadi B. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer. 1996;73(7):849-855.

    Not in our library10.1038/bjc.1996.151

21. 21.

    Hooijberg J. H., Broxterman H. J., Kool M., Assaraf Y. G., Peters G. J., Noordhuis P., Scheper R. J., Borst P., Pinedo H. M., Jansen G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 1999;59(11):2532-2535.

    Not in our library

22. 22.

    Hyafil F., Vergely C., Du Vignaud P., Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 1993;53(19):4595-4602.

    Not in our library

23. 23.

    Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J. 1997;327(Pt 1):305-310.

    Not in our library10.1042/bj3270305

24. 24.

    Juliano R. L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455(1):152-162.

    Not in our library10.1016/0005-2736(76)90160-7

25. 25.

    Keppler D., Jedlitschky G., Leier I. Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol. 1998;292:607-616.

    Not in our library10.1016/s0076-6879(98)92047-x

26. 26.

    Kool M., de Haas M., Scheffer G. L., Scheper R. J., van Eijk M. J., Juijn J. A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997;57(16):3537-3547.

    Not in our library

27. 27.

    Kool M., van der Linden M., de Haas M., Baas F., Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 1999;59(1):175-182.

    Not in our library

28. 28.

    Leier I., Jedlitschky G., Buchholz U., Cole S. P., Deeley R. G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 1994;269(45):27807-27810.

    Not in our library

29. 29.

    Loe D. W., Almquist K. C., Deeley R. G., Cole S. P. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem. 1996;271(16):9675-9682.

    Not in our library10.1074/jbc.271.16.9675

30. 30.

    Loe D. W., Deeley R. G., Cole S. P. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res. 1998;58(22):5130-5136.

    Not in our library

31. 31.

    Masuda M., I'izuka Y., Yamazaki M., Nishigaki R., Kato Y., Ni'inuma K., Suzuki H., Sugiyama Y. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res. 1997;57(16):3506-3510.

    Not in our library

32. 32.

    Miller D. W., Batrakova E. V., Kabanov A. V. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm Res. 1999;16(3):396-401.

    Not in our library10.1023/a:1018873702411

33. 33.

    Miller D. W., Batrakova E. V., Waltner T. O., Alakhov VYu, Kabanov A. V. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjug Chem. 1997;8(5):649-657.

    Not in our library10.1021/bc970118d

34. 34.

    Nerurkar M. M., Ho N. F., Burton P. S., Vidmar T. J., Borchardt R. T. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. J Pharm Sci. 1997;86(7):813-821.

    Not in our library10.1021/js960483y

35. 35.

    Oude Elferink R. P., Bakker C. T., Jansen P. L. Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells). Biochem J. 1993;290(Pt 3):759-764.

    Not in our library10.1042/bj2900759

36. 36.

    Rappa G., Lorico A., Flavell R. A., Sartorelli A. C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 1997;57(23):5232-5237.

    Not in our library

37. 37.

    Rowinsky E. K., Smith L., Wang Y. M., Chaturvedi P., Villalona M., Campbell E., Aylesworth C., Eckhardt S. G., Hammond L., Kraynak M. Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. J Clin Oncol. 1998;16(9):2964-2976.

    Not in our library10.1200/jco.1998.16.9.2964

38. 38.

    Sarkadi B., Müller M. Search for specific inhibitors of multidrug resistance in cancer. Semin Cancer Biol. 1997;8(3):171-182.

    Not in our library10.1006/scbi.1997.0069

39. 39.

    Schinkel A. H., Wagenaar E., van Deemter L., Mol C. A., Borst P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest. 1995;96(4):1698-1705.

    Not in our library10.1172/jci118214

40. 40.

    Schuetz J. D., Connelly M. C., Sun D., Paibir S. G., Flynn P. M., Srinivas R. V., Kumar A., Fridland A. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med. 1999;5(9):1048-1051.

    Not in our library10.1038/12487

41. 41.

    Smith A. J., Mayer U., Schinkel A. H., Borst P. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum. J Natl Cancer Inst. 1998;90(15):1161-1166.

    Not in our library10.1093/jnci/90.15.1161

42. 42.

    Szabó K., Welker E., Bakos, Müller M., Roninson I., Váradi A., Sarkadi B. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. J Biol Chem. 1998;273(17):10132-10138.

    Not in our library10.1074/jbc.273.17.10132

43. 43.

    Twentyman P. R., Bleehen N. M. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected]. Eur J Cancer. 1991;27(12):1639-1642.

    Not in our library10.1016/0277-5379(91)90435-g

44. 44.

    Venne A., Li S., Mandeville R., Kabanov A., Alakhov V. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 1996;56(16):3626-3629.

    Not in our library

45. 45.

    Wallstab A., Koester M., Böhme M., Keppler D. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918. Br J Cancer. 1999;79(7-8):1053-1060.

    Not in our library10.1038/sj.bjc.6690169

46. 46.

    Yanagisawa T., Newman A., Coley H., Renshaw J., Pinkerton C. R., Pritchard-Jones K. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma. Br J Cancer. 1999;80(8):1190-1196.

    Not in our library10.1038/sj.bjc.6990485

47. 47.

    Zaman G. J., Flens M. J., van Leusden M. R., de Haas M., Mülder H. S., Lankelma J., Pinedo H. M., Scheper R. J., Baas F., Broxterman H. J. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1994;91(19):8822-8826.

    Not in our library10.1073/pnas.91.19.8822

Cited by papers we hold 2

• ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. · 2005
  No notice
• Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion · 2001
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.